You are required to be logged in to access the full website
Click here if you have forgotten your username or password
17 January 2025 - Biopharmaceutical company Zai Lab Limited (NASDAQ:ZLAB) (HKEX:9688) announced on Friday that China's National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for KarXT (xanomeline and trospium...
17 January 2025 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) announced on Friday that Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved by the US Food and Drug Administration (F...
UCB launches 320 mg/2 mL single-injection administration option for BIMZELX (bimekizumab-bkzx) in US
17 January 2025 - Biopharmaceutical company UCB (Euronext Brussels:UCB) announced on Thursday that it has launched a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX (bimekizumab-bkzx).This is in addition to...
17 January 2025 - Drug delivery technology company Concept Medical Inc announced on Thursday that the first patient has been enrolled in the 'MAGICAL BTK' randomised controlled trial of MagicTouch PTA Sirolimus Coated Balloon (SCB) versus s...
17 January 2025 - Australian biopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX) (Nasdaq: TLX) announced on Thursday that it has received a positive decision on the Marketing Authorisation Application (MAA) for its prostate cancer PET ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe